Nature Communications (Oct 2021)
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
- Jia Wei,
- Philippa C. Matthews,
- Nicole Stoesser,
- Thomas Maddox,
- Luke Lorenzi,
- Ruth Studley,
- John I. Bell,
- John N. Newton,
- Jeremy Farrar,
- Ian Diamond,
- Emma Rourke,
- Alison Howarth,
- Brian D. Marsden,
- Sarah Hoosdally,
- E. Yvonne Jones,
- David I. Stuart,
- Derrick W. Crook,
- Tim E. A. Peto,
- Koen B. Pouwels,
- A. Sarah Walker,
- David W. Eyre,
- the COVID-19 Infection Survey team
Affiliations
- Jia Wei
- Nuffield Department of Medicine, University of Oxford
- Philippa C. Matthews
- Nuffield Department of Medicine, University of Oxford
- Nicole Stoesser
- Nuffield Department of Medicine, University of Oxford
- Thomas Maddox
- Office for National Statistics
- Luke Lorenzi
- Office for National Statistics
- Ruth Studley
- Office for National Statistics
- John I. Bell
- Office of the Regius Professor of Medicine, University of Oxford
- John N. Newton
- Health Improvement Directorate, Public Health England
- Jeremy Farrar
- Wellcome Trust
- Ian Diamond
- Office for National Statistics
- Emma Rourke
- Office for National Statistics
- Alison Howarth
- Nuffield Department of Medicine, University of Oxford
- Brian D. Marsden
- Nuffield Department of Medicine, University of Oxford
- Sarah Hoosdally
- Nuffield Department of Medicine, University of Oxford
- E. Yvonne Jones
- Nuffield Department of Medicine, University of Oxford
- David I. Stuart
- Nuffield Department of Medicine, University of Oxford
- Derrick W. Crook
- Nuffield Department of Medicine, University of Oxford
- Tim E. A. Peto
- Nuffield Department of Medicine, University of Oxford
- Koen B. Pouwels
- Nuffield Department of Medicine, University of Oxford
- A. Sarah Walker
- Nuffield Department of Medicine, University of Oxford
- David W. Eyre
- Big Data Institute, Nuffield Department of Population Health, University of Oxford
- the COVID-19 Infection Survey team
- DOI
- https://doi.org/10.1038/s41467-021-26479-2
- Journal volume & issue
-
Vol. 12,
no. 1
pp. 1 – 12
Abstract
Most people who are infected with SARS-CoV-2 seroconvert within a few weeks, but the determinants and duration of the antibody response are not known. Here, the authors characterise these features of the immune response using data from a large representative community sample of the UK population.
